Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00318097 · ClinicalTrials.gov registry record

Histamine Responsiveness in McCune-Albright Syndrome

A clinical trial of McCune Albright Syndrome, sponsored by Children's Mercy Hospital Kansas City.

Completed
Registry status
22
Enrollment target
1
Study location

NCT00318097: Completed study of McCune Albright Syndrome, sponsored by Children's Mercy Hospital Kansas City.

NCT00318097 is a study of McCune Albright Syndrome that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 22 participants, below the 370-participant average among 3 other McCune Albright Syndrome trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00318097, a study of McCune Albright Syndrome, has completed, sponsored by Children's Mercy Hospital Kansas City.

COMPLETED
Registry status
22 participants
Enrollment target
1
Study location

Study Summary

McCune-Albright syndrome (MAS) is a syndrome caused by a genetic mutation that causes a specific protein in the body called a G protein to be constantly active. Children with McCune-Albright syndrome classically have early puberty, areas of increased skin pigmentation, and bone lesions resulting from the constant activity of the specific protein involved. Histamines are known to play a role in allergies and related allergic problems. The effects of histamines are controlled by the same G protein that is overly active in McCune-Albright syndrome. Thus, one could predict that patients with McCune-Albright may be at high risk for allergic problems. To date, no studies have documented any form of histamine excess or allergic difficulties in patients with McCune-Albright syndrome. However, the investigators have made the observation that a high percentage of their patients with MAS exhibit a range of allergic symptoms, from mild symptoms, to severe, life-threatening symptoms. The purpose of this study is to demonstrate increased histamine response by using a histamine skin test in patients with MAS. If increased reactions to histamines can be documented in MAS patients when compared to controls, severe and potentially life threatening allergic reactions in children with MAS could be anticipated and avoided.

Conditions Studied

Study Locations (1)

Missouri

  • Children's Mercy Hospitals and Clinics - Kansas City

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2004-08-01
Est. Completion 2007-08-01

What the finished NCT00318097 record still lists

NCT00318097 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 370-participant average among 3 other McCune Albright Syndrome trials with a reported enrollment target (94% lower).

The record links to 1 condition, with McCune Albright Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT00318097 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT00318097 about?

NCT00318097 is a clinical study titled "Histamine Responsiveness in McCune-Albright Syndrome". McCune-Albright syndrome (MAS) is a syndrome caused by a genetic mutation that causes a specific protein in the body called a G protein to be constantly active. Children with McCune-Albright syndrome classically have early puberty, areas of increased skin pigmentation, and bone lesions resulting fro...

What is the current status of trial NCT00318097?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2004-08-01. Estimated completion is 2007-08-01.

What conditions does trial NCT00318097 study?

This clinical trial studies the following conditions: McCune Albright Syndrome.

Who is sponsoring clinical trial NCT00318097?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00318097 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for McCune Albright Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00318097, the US trial registry maintained by the National Library of Medicine. NCT00318097 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.